Abbvie Receives Positive Chmp Opinion for Mirvetuximab Soravtansine (Elahere®) for the Treatment of Certain Adult Ovarian Cancer
艾伯維公司獲得Mirvetuximab Soravtansine(Elahere®)治療某些成年卵巢癌的積極CHMP意見
Abbvie Receives Positive Chmp Opinion for Mirvetuximab Soravtansine (Elahere®) for the Treatment of Certain Adult Ovarian Cancer
艾伯維公司獲得Mirvetuximab Soravtansine(Elahere®)治療某些成年卵巢癌的積極CHMP意見
譯文內容由第三人軟體翻譯。